FFCP PHASE1:Mm9::chr18:21130153..21130163,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=112|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr18:21130153..21130163,+|id=chr18:21130153..21130163,+|ontology_enrichment_celltype=CL:0000325!1.66e-44!2;CL:0000217!1.66e-44!2;CL:0000328!1.66e-44!2;CL:0002573!1.66e-44!2;CL:0002376!1.66e-44!2;CL:0000218!1.66e-44!2;CL:0000692!1.66e-44!2;CL:0002377!1.66e-44!2;CL:0002375!1.66e-44!2;CL:0000215!4.03e-30!3;CL:0000630!4.03e-30!3;CL:0000333!7.63e-10!10;CL:0000095!7.63e-10!10;CL:0000243!7.63e-10!10;CL:0000123!7.63e-10!10;CL:0000125!7.63e-10!10;CL:0000030!7.63e-10!10;CL:0000339!7.63e-10!10|ontology_enrichment_celltype_v019_2=CL:0000217,4.52e-44,2;CL:0000328,4.52e-44,2;CL:0002573,4.52e-44,2;CL:0002376,4.52e-44,2;CL:0000218,4.52e-44,2;CL:0000692,4.52e-44,2;CL:0002377,4.52e-44,2;CL:0002375,4.52e-44,2;CL:0000215,5.61e-30,3;CL:0000333,4.12e-10,10;CL:0000095,4.12e-10,10;CL:0000243,4.12e-10,10;CL:0000123,4.12e-10,10;CL:0000125,4.12e-10,10;CL:0000030,4.12e-10,10;CL:0000339,4.12e-10,10|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000010!4.82e-09!11|ontology_enrichment_uberon_v019_2=UBERON:0000010,2.51e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.681535739998656,3.55186332501892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274561413188081,0,0,0.312037673114561,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr18:21130153..21130163,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=112 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr18:21130153..21130163,+ | |||
|description=CAGE_peak_at_chr18:21130153..21130163,+ | |||
|id=chr18:21130153..21130163,+ | |||
|ontology_enrichment_celltype=CL:0000325!1.66e-44!2;CL:0000217!1.66e-44!2;CL:0000328!1.66e-44!2;CL:0002573!1.66e-44!2;CL:0002376!1.66e-44!2;CL:0000218!1.66e-44!2;CL:0000692!1.66e-44!2;CL:0002377!1.66e-44!2;CL:0002375!1.66e-44!2;CL:0000215!4.03e-30!3;CL:0000630!4.03e-30!3;CL:0000333!7.63e-10!10;CL:0000095!7.63e-10!10;CL:0000243!7.63e-10!10;CL:0000123!7.63e-10!10;CL:0000125!7.63e-10!10;CL:0000030!7.63e-10!10;CL:0000339!7.63e-10!10 | |||
|ontology_enrichment_celltype_v019_2=CL:0000217,4.52e-44,2;CL:0000328,4.52e-44,2;CL:0002573,4.52e-44,2;CL:0002376,4.52e-44,2;CL:0000218,4.52e-44,2;CL:0000692,4.52e-44,2;CL:0002377,4.52e-44,2;CL:0002375,4.52e-44,2;CL:0000215,5.61e-30,3;CL:0000333,4.12e-10,10;CL:0000095,4.12e-10,10;CL:0000243,4.12e-10,10;CL:0000123,4.12e-10,10;CL:0000125,4.12e-10,10;CL:0000030,4.12e-10,10;CL:0000339,4.12e-10,10 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000010!4.82e-09!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000010,2.51e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.681535739998656,3.55186332501892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274561413188081,0,0,0.312037673114561,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr18:21130153..21130163,+ | |||
}} |
Latest revision as of 14:08, 5 August 2015
Short description: | p@chr18:21130153..21130163, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr18:21130153..21130163, + |
Coexpression cluster: | MCL_coexpression_mm9:112 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data